Western blot analysis results revealed that transfection of shRNA-S100A16 substantially inhibited the expression level of S100A16 protein in renal cancer 796-P cells compared with the control group (shRNA-control; Figure 8(c)). Here, S100A16 is linked to renal carcinoma.